0001209191-11-042547.txt : 20110804
0001209191-11-042547.hdr.sgml : 20110804
20110804200804
ACCESSION NUMBER: 0001209191-11-042547
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110802
FILED AS OF DATE: 20110804
DATE AS OF CHANGE: 20110804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOWE CHRISTOPHER P.
CENTRAL INDEX KEY: 0001376260
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34637
FILM NUMBER: 111011889
MAIL ADDRESS:
STREET 1: HANSEN MEDICAL, INC.
STREET 2: 380 N. BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anthera Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001316175
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201852016
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 856-5600
MAIL ADDRESS:
STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2011-08-02
0
0001316175
Anthera Pharmaceuticals Inc
ANTH
0001376260
LOWE CHRISTOPHER P.
C/O ANTHERA PHARMACEUTICALS, INC.
25801 INDUSTRIAL BOULEVARD, SUITE B
HAYWARD
CA
94545
0
1
0
0
Chief Financial Officer & CBO
Common Stock
2011-08-02
4
S
0
4700
7.2752
D
4937
I
By spouse
Common Stock
2011-08-02
4
S
0
300
7.9267
D
4637
I
By spouse
Common Stock
2011-08-03
4
S
0
14600
6.8789
D
51151
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2011.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $7.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.78 to $8.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2011.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.77 to $7.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions, and 1,606 shares acquired under the Issuer 2010 Employee Stock Purchase Plan on June 30, 2011.
/s/ Bradley A. Bugdanowitz, by power of attorney
2011-08-04